C. Rébé
发表
E. Solary,
W. Vainchenker,
C. Garrido,
2002,
Blood.
F. Ghiringhelli,
C. Rébé,
2015,
Future oncology.
B. Ryffel,
F. Végran,
R. Boidot,
2015,
Nature Immunology.
F. Végran,
F. Ghiringhelli,
B. Routy,
2021,
Journal for ImmunoTherapy of Cancer.
E. Solary,
S. Grant,
M. Fontenay,
2007,
Blood.
E. Solary,
S. Grant,
A. Dubart-Kupperschmitt,
2006
.
Wilfrid Boireau,
Grégoire Mignot,
B. Ryffel,
2012,
Nature Medicine.
E. Solary,
N. Debili,
O. Sordet,
2004,
Blood.
E. Solary,
S. Grant,
M. Fontenay,
2006
.
E. Solary,
S. Grant,
M. Fontenay,
2009
.
F. Ghiringhelli,
C. Rébé,
V. Derangère,
2015,
Molecular & cellular oncology.
F. Végran,
S. Causse,
A. Hichami,
2014,
Cell Death and Differentiation.
B. Chauffert,
L. Zitvogel,
E. Solary,
2010,
The Journal of clinical investigation.
F. Ghiringhelli,
C. Rébé,
2020,
Cancers.
E. Solary,
S. Grant,
M. Fontenay,
2004
.
F. Ghiringhelli,
C. Rébé,
Lucie Demontoux,
2019,
Biomolecules.
F. Végran,
F. Ghiringhelli,
Pierre Vabres,
2013,
The Journal of investigative dermatology.
Aude Plé,
A. Hichami,
N. Khan,
2007,
Molecular Pharmacology.
F. Ghiringhelli,
C. Rébé,
V. Derangère,
2019,
International journal of cancer.
J. Pais de Barros,
A. Hichami,
F. Ghiringhelli,
2019,
Cell Death & Disease.
P. Gambert,
L. Lagrost,
M. Ishibashi,
2013,
Biochemical pharmacology.
C. Rébé,
P. Martine,
2019,
International Journal of Molecular Sciences.
F. Ghiringhelli,
C. Rébé,
V. Derangère,
2020,
Frontiers in Cell and Developmental Biology.
E. Solary,
A. Hammann,
N. Droin,
2001,
Blood.
C. Garrido,
F. Ghiringhelli,
C. Rébé,
2020,
British journal of pharmacology.
S. Causse,
F. Ghiringhelli,
L. Arnould,
2022,
Cell Death & Disease.
C. Garrido,
F. Ghiringhelli,
C. Rébé,
2019,
Cell Death & Disease.
C. Garrido,
F. Ghiringhelli,
C. Rébé,
2020,
Journal for ImmunoTherapy of Cancer.
E. Solary,
M. Fontenay,
F. Verdier,
2006,
Journal of Biological Chemistry.
A. Hichami,
F. Ghiringhelli,
C. Rébé,
2012,
Anti-cancer agents in medicinal chemistry.
E. Solary,
S. Grant,
M. Fontenay,
2002
.
S. Causse,
A. Hichami,
F. Ghiringhelli,
2016,
Oncogene.
F. Ghiringhelli,
S. Ladoire,
C. Rébé,
2011
.
E. Solary,
O. Sordet,
C. Rébé,
2002,
Leukemia.
E. Solary,
S. Grant,
M. Fontenay,
2006
.
B. Chauffert,
L. Zitvogel,
E. Solary,
2010
.
F. Ghiringhelli,
C. Rébé,
Nicolas Roussot,
2022,
Cells.
E. Solary,
S. Grant,
M. Fontenay,
2004
.
B. Ryffel,
F. Végran,
J. Pallandre,
2012,
Immunity.
J. Vincent,
F. Ghiringhelli,
S. Ladoire,
2010,
Cancer research.
F. Végran,
R. Boidot,
J. Vincent,
2016,
Cancer research.
Jean-David Fumet,
F. Ghiringhelli,
C. Richard,
2020,
Oncoimmunology.
Takashi Tsuruo,
David J. Kerr,
Qiang Yu,
2002
.
E. Solary,
A. Hammann,
N. Droin,
2001,
Oncogene.
J. Pais de Barros,
L. Lagrost,
C. Magnani,
2020,
Cell reports.
E. Solary,
S. Grant,
M. Fontenay,
2006
.
P. Pagès,
C. Coutant,
C. Garrido,
2020,
Journal of extracellular vesicles.
E. Solary,
P. Gambert,
M. Cherkaoui-Malki,
2003,
Journal of Biological Chemistry.
L. Corcos,
E. Solary,
C. Garrido,
2013
.
E. Solary,
C. Rébé,
R. Filomenko,
2006,
Oncogene.
E. Solary,
N. Droin,
O. Sordet,
2002
.
L. Corcos,
E. Solary,
C. Garrido,
2001,
Blood.
F. Végran,
F. Ghiringhelli,
C. Rébé,
2013,
JAK-STAT.
Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 Deacetylation.
R. Boidot,
F. Ghiringhelli,
S. Ladoire,
2017,
Cell reports.
L. Corcos,
A. Berthier,
S. Lemaire-Ewing,
2009,
Cell Biology and Toxicology.
G. Kroemer,
E. Solary,
B. Bonnotte,
2002,
Oncogene.
B. Ryffel,
F. Végran,
R. Boidot,
2014,
Nature Immunology.
B. Ryffel,
F. Végran,
R. Boidot,
2022,
Nature Immunology.
A. Hammann,
C. Garrido,
A. de Thonel,
2016,
Journal of the National Cancer Institute.
B. Ryffel,
F. Végran,
A. Hichami,
2013,
Cancer research.
E. Solary,
S. Grant,
M. Fontenay,
2002
.
J. Pais de Barros,
A. Hichami,
F. Ghiringhelli,
2019,
Cell Death & Disease.
R. Boidot,
Jean-David Fumet,
L. Bengrine,
2016,
Oncotarget.
B. Ryffel,
F. Végran,
R. Boidot,
2022,
Nature Immunology.
Annie Costa,
Eric Steinmetz,
E. Solary,
2009,
Circulation research.
P. Fumoleau,
S. Ladoire,
L. Arnould,
2011,
British Journal of Cancer.
F. Ghiringhelli,
C. Rébé,
Anaïs Perrichet,
2020,
Cancers.
F. Ghiringhelli,
C. Rébé,
2019,
Cancers.
L. Bengrine,
F. Ghiringhelli,
L. Arnould,
2019,
Advances in Therapy.
B. Chauffert,
P. Fumoleau,
J. Vincent,
2010
.
F. Penault-Llorca,
R. Boidot,
P. Fumoleau,
2012,
Annals of oncology : official journal of the European Society for Medical Oncology.
B. Chauffert,
P. Fumoleau,
J. Vincent,
2010,
Breast Cancer Research and Treatment.
A. Hichami,
N. Khan,
B. Murtaza,
2017
.
C. Rébé,
V. Derangère,
2016
.
C. Coutant,
P. Fumoleau,
F. Ghiringhelli,
2011,
The Journal of pathology.
F. Ghiringhelli,
C. Rébé,
M. Bruchard,
2012,
Journal of biomedicine & biotechnology.
C. Borg,
A. Bertaut,
F. Ghiringhelli,
2018,
Oncoimmunology.
F. Végran,
F. Ghiringhelli,
S. Ladoire,
2013,
PloS one.
E. Solary,
P. Gambert,
G. Laurent,
2004,
Oncogene.
P. Gambert,
L. Lagrost,
M. Ishibashi,
2012,
PloS one.
A. Hichami,
B. Murtaza,
F. Ghiringhelli,
2017,
PloS one.
E. Solary,
B. Bonnotte,
P. Gambert,
2009,
Arteriosclerosis, thrombosis, and vascular biology.
R. Boidot,
F. Ghiringhelli,
S. Ladoire,
2015,
Oncotarget.
C. Garrido,
F. Ghiringhelli,
C. Rébé,
2019,
Cell Death & Disease.
E. Solary,
C. Rébé,
S. Plenchette,
2003,
Current medicinal chemistry. Anti-cancer agents.
L. Corcos,
E. Solary,
J. Bruey,
2001,
Therapie.
F. Ghiringhelli,
S. Ladoire,
C. Rébé,
2022,
Clinical cancer research : an official journal of the American Association for Cancer Research.
B. Ryffel,
F. Végran,
R. Boidot,
2015,
Nature Immunology.
Jean-David Fumet,
L. Arnould,
B. Collin,
2022,
Cancer cell.
F. Végran,
R. Boidot,
J. Vincent,
2016,
Cancer research.
F. Ghiringhelli,
C. Rébé,
V. Derangère,
2014
.
F. Ghiringhelli,
C. Rébé,
2023,
Immunological reviews.
B. Ryffel,
F. Végran,
R. Boidot,
2015,
Nature Immunology.